{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T05:22:34Z","timestamp":1742966554360,"version":"3.40.3"},"publisher-location":"Cham","reference-count":47,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030384739"},{"type":"electronic","value":"9783030384746"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-38474-6_7","type":"book-chapter","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:06:35Z","timestamp":1589393195000},"page":"121-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Replacement Hormone Therapy for Gender Dysphoria and Congenital Sexual Anomalies"],"prefix":"10.1007","author":[{"given":"Angelica","family":"Mare\u015f Miceli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"7_CR1","unstructured":"Martine Rothblatt. The apartheid of sex."},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013. p. 451\u20139.","edition":"5"},{"key":"7_CR3","unstructured":"Fris\u00e9n L, S\u00f6der O, Rydelius PA. Dramatic increase of gender dysphoria in youth. L\u00e4kartidningen. 2017."},{"issue":"1","key":"7_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MED.0000000000000378","volume":"25","author":"J Cartaya","year":"2018","unstructured":"Cartaya J, Lopez X. Gender dysphoria in youth: a review of recent literature. Curr Opin Endocrinol Diabetes Obes. 2018;25(1):44\u20138.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jsm.12817","volume":"12","author":"M Aitken","year":"2015","unstructured":"Aitken M, Steensma TD, Blanchard R, et al. Evidence for an altered sex ratio in clinic-referred adolescents with gender dysphoria. J Sex Med. 2015;12:756\u201363.","journal-title":"J Sex Med"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jamainternmed.2017.1460","volume":"177","author":"CG Streed Jr","year":"2017","unstructured":"Streed CG Jr, McCarthy EP, Haas JS. Association between gender minority status and self-reported physical and mental health in the United States. JAMA Intern Med. 2017;177:1210\u20132.","journal-title":"JAMA Intern Med"},{"issue":"11","key":"7_CR7","first-page":"645","volume":"98","author":"DA Klein","year":"2018","unstructured":"Klein DA, Paradise SL, Goodwin ET. Caring for transgender and gender-diverse persons: what clinicians should know. Am Fam Physician. 2018;98(11):645\u201353.","journal-title":"Am Fam Physician"},{"key":"7_CR8","unstructured":"WPATH. Clarification on medical necessity of treatment, sex reassignment, and insurance coverage for transgender and transsexual people worldwide [Internet]. \nhttp:\/\/www.wpath.org\/site_page.cfm?pk_association_webpage_menu=1352&pk_association_webpage=3947"},{"issue":"4","key":"7_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15532739.2011.700873","volume":"13","author":"E Coleman","year":"2012","unstructured":"Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism. 2012;13(4):165\u2013232.","journal-title":"Int J Transgenderism"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/1471-0528.15258","volume":"125","author":"R Joint","year":"2018","unstructured":"Joint R, Chen ZE, Cameron S. Breast and reproductive cancers in the transgender population: a systematic review [published online ahead of print April 28, 2018]. BJOG. 2018;125:1505. \nhttps:\/\/doi.org\/10.1111\/1471-0528.15258\n\n.","journal-title":"BJOG"},{"issue":"11","key":"7_CR11","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, et al. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2017;102(11):3914\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"7_CR12","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1210\/jc.2017-01642","volume":"102","author":"N Singh-Ospina","year":"2017","unstructured":"Singh-Ospina N, Maraka S, Rodriguez-Gutierrez R, et al. Effect of sex steroids on the bone health of transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2017;102(11):3904\u201313.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/cen.12753","volume":"83","author":"MC Meriggiola","year":"2015","unstructured":"Meriggiola MC, Gava G. Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen. Clin Endocrinol. 2015;83(5):597\u2013606.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"7_CR14","first-page":"55","volume":"2","author":"JD Weinand","year":"2015","unstructured":"Weinand JD, Safer JD. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol. 2015;2(2):55\u201360.","journal-title":"J Clin Transl Endocrinol"},{"key":"7_CR15","unstructured":"Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2nd ed. 2016. \nhttp:\/\/transhealth.ucsf.edu\/protocols\n\n. Accessed 5 July 2018."},{"key":"7_CR16","unstructured":"Endocrine Society Updates Guidelines on Transgender Medical Care. Veronica Hackenthal. 2017. \nwww.medscape.com"},{"issue":"11","key":"7_CR17","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine. Society clinical practice guideline [published correction appears in J Clin Endocrinol Metab. 2018;103(2):699]. J Clin Endocrinol Metab. 2017;102(11):3869\u2013903.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"7_CR18","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1210\/jc.2002-021967","volume":"88","author":"E Moore","year":"2003","unstructured":"Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab. 2003;88(8):3467\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","volume":"149","author":"GR Brown","year":"2015","unstructured":"Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2015;149(1):191\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7_CR20","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/and.12208","volume":"46","author":"L Gooren","year":"2014","unstructured":"Gooren L, Morgentaler A. Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens. Andrologia. 2014;46(10):1156\u201360.","journal-title":"Andrologia"},{"issue":"7\u20138","key":"7_CR21","doi-asserted-by":"publisher","first-page":"E544","DOI":"10.5489\/cuaj.175","volume":"7","author":"R Turo","year":"2013","unstructured":"Turo R, Jallad S, Prescott S, Cross WR. Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy. Can Urol Assoc J. 2013;7(7\u20138):E544\u20136.","journal-title":"Can Urol Assoc J"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1210\/jc.2017-00359","volume":"102","author":"DI Spratt","year":"2017","unstructured":"Spratt DI, Stewart II, Savage C, et al. Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: demonstration in female-to-male transgender patients. J Clin Endocrinol Metab. 2017;102:2349\u201355.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1055\/s-0038-1657788","volume":"40","author":"LBF Costa","year":"2018","unstructured":"Costa LBF, Rosa-E-Silva ACJS, Medeiros SF, Nacul AP, Carvalho BR, Benetti-Pinto CL, Yela DA, Maciel GAR, Soares J\u00fanior JM, Maranh\u00e3o TMO. Recommendations for the use of testosterone in male transgender. Rev Bras Ginecol Obstet. 2018;40(5):275\u201380.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"10","key":"7_CR24","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","volume":"9","author":"K Wierckx","year":"2012","unstructured":"Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012;9(10):2641\u201351.","journal-title":"J Sex Med"},{"issue":"5","key":"7_CR25","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.ajog.2010.12.057","volume":"204","author":"RR Urban","year":"2011","unstructured":"Urban RR, Teng NNH, Kapp DS. Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. Am J Obstet Gynecol. 2011;204(5):e9\u201312.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","volume":"20","author":"M Grynberg","year":"2010","unstructured":"Grynberg M, Fanchin R, Dubost G, Colau J-C, Br\u00e9mont-Weil C, Frydman R, et al. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online. 2010;20(4):553\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"7_CR27","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1111\/j.1743-6109.2009.01380.x","volume":"6","author":"AM Perrone","year":"2009","unstructured":"Perrone AM, Cerpolini S, Maria Salfi NC, Ceccarelli C, De Giorgi LB, Formelli G, et al. Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. J Sex Med. 2009;6(11):3193\u2013200.","journal-title":"J Sex Med"},{"issue":"4","key":"7_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000094097","volume":"62","author":"DS Dizon","year":"2006","unstructured":"Dizon DS, Tejada-Berges T, Koelliker S, Steinhoff M, Granai CO. Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient. Gynecol Obstet Investig. 2006;62(4):226\u20138.","journal-title":"Gynecol Obstet Investig"},{"issue":"3","key":"7_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1006\/gyno.1999.5720","volume":"76","author":"JJ Hage","year":"2000","unstructured":"Hage JJ, Dekker JJ, Karim RB, Verheijen RH, Bloemena E. Ovarian cancer in female-to-male transsexuals: report of two cases. Gynecol Oncol. 2000;76(3):413\u20135.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jcem-62-1-16","volume":"62","author":"W Futterweit","year":"1986","unstructured":"Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab. 1986;62(1):16\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0015-0282(16)49543-9","volume":"46","author":"W Futterweit","year":"1986","unstructured":"Futterweit W, Deligdisch L. Effects of androgens on the ovary. Fertil Steril. 1986;46(2):343\u20135.","journal-title":"Fertil Steril"},{"issue":"4","key":"7_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-13-0493","volume":"169","author":"K Wierckx","year":"2013","unstructured":"Wierckx K, Elaut E, Declercq E, Heylens G, De Cuypere G, Taes Y, et al. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur J Endocrinol. 2013;169(4):471\u20138.","journal-title":"Eur J Endocrinol"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0015-0282(16)59942-7","volume":"49","author":"American Fertility Society","year":"1988","unstructured":"American Fertility Society. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, M\u00fcllerian anomalies and intrauterine adhesions. Fertil Steril. 1988;49:944\u201355.","journal-title":"Fertil Steril"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1259\/bjr\/99354802","volume":"82","author":"TM Chandler","year":"2009","unstructured":"Chandler TM, Machan LS, Cooperberg PL, Harris AC, Chang SD. M\u00fcllerian duct anomalies: from diagnosis to intervention. Pictorial review. Brit J Radiol. 2009;82:1034\u201342.","journal-title":"Brit J Radiol"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10397-011-0724-2","volume":"9","author":"GF Grimbizis","year":"2012","unstructured":"Grimbizis GF, Campo R, Gordts S, Brucker S, Gergolet M, Tanos V, et al. Clinical approach for the classification of congenital uterine malformations. Gynecol Surg. 2012;9:119\u201329.","journal-title":"Gynecol Surg"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/humrep\/det098","volume":"28","author":"GF Grimbizis","year":"2013","unstructured":"Grimbizis GF, Gordts S, Spiezio Sardo A, Brucker S, De Angelis C, Gergolet M, et al. The ESHRE\/ESGE consensus on the classification of female genital tract congenital anomalies. Hum Reprod. 2013;28:2032\u201344.","journal-title":"Hum Reprod"},{"issue":"5","key":"7_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s13244-016-0515-4","volume":"7","author":"P Aci\u00e9n","year":"2016","unstructured":"Aci\u00e9n P, Aci\u00e9n M. Diagnostic imaging and cataloguing of female genital malformations. Insights Imaging. 2016;7(5):713\u201326.","journal-title":"Insights Imaging"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bpobgyn.2017.11.005","volume":"48","author":"SF Witchel","year":"2018","unstructured":"Witchel SF. Disorders of sex development. Best Pract Res Clin Obstet Gynaecol. 2018;48:90\u2013102.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000442975","volume":"85","author":"PA Lee","year":"2016","unstructured":"Lee PA, Nordenstr\u00f6m A, Houk CP, et al. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr. 2016;85:158\u201380.","journal-title":"Horm Res Paediatr"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.beem.2007.06.003","volume":"21","author":"IA Hughes","year":"2007","unstructured":"Hughes IA, Nihoul-F\u00e9k\u00e9t\u00e9 C, Thomas B, et al. Consequences of the ESPE\/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab. 2007;21:351\u201365.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.semperi.2017.03.014","volume":"41","author":"MJ Chen","year":"2017","unstructured":"Chen MJ, McCann-Crosby B, Gunn S, et al. Fluidity models in ancient Greece and current practices of sex assignment. Semin Perinatol. 2017;41:206\u201313.","journal-title":"Semin Perinatol"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jpag.2015.03.011","volume":"29","author":"V Patel","year":"2016","unstructured":"Patel V, Casey RK, Gomez-Lobo V. Timing of gonadectomy in patients with complete androgen insensitivity syndrome-current recommendations and future directions. J Pediatr Adolesc Gynecol. 2016;29:320\u20135.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"7_CR43","first-page":"668","volume":"7","author":"L Laurian","year":"1971","unstructured":"Laurian L, Finkelstein JO, Soferman N, Loewenthal M, Deligdisch L. Testicular feminization syndrome. Isr J Med Sci. 1971;7(5):668\u201373.","journal-title":"Isr J Med Sci"},{"issue":"2","key":"7_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1515\/jpem-2015-0175","volume":"29","author":"D Becker","year":"2016","unstructured":"Becker D, Wain LM, Chong YH, Gosai SJ, Henderson NK, Milburn J, Stott V, Wheeler BJ. Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) before, during, and after puberty\u2014a case series. J Pediatr Endocrinol Metab. 2016;29(2):173\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"7_CR45","doi-asserted-by":"crossref","unstructured":"Altchek A, Deligdisch L. Pediatric adolescent and young adult gynecology: Blackwell Publishing; 2009.","DOI":"10.1002\/9781444311662"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(14)61728-1","volume":"385","author":"M Br\u00e4nnstr\u00f6m","year":"2015","unstructured":"Br\u00e4nnstr\u00f6m M, Johannesson L, Bokstr\u00f6m H, et al. Livebirth after uterus transplantation. Lancet. 2015;385:607\u201316.","journal-title":"Lancet"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/ajt.14737","volume":"18","author":"G Testa","year":"2018","unstructured":"Testa G, McKenna GJ, Gunby RT Jr, et al. First live birth after uterus transplantation in the United States. Am Transplant. 2018;18:1270\u20134.","journal-title":"Am Transplant"}],"container-title":["Advances in Experimental Medicine and Biology","Hormonal Pathology of the Uterus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-38474-6_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T05:04:16Z","timestamp":1589432656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-38474-6_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030384739","9783030384746"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-38474-6_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"14 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}